These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition. Stimson RH; Andrew R; McAvoy NC; Tripathi D; Hayes PC; Walker BR Diabetes; 2011 Mar; 60(3):720-5. PubMed ID: 21266326 [TBL] [Abstract][Full Text] [Related]
5. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Walker BR Proc Nutr Soc; 2007 Feb; 66(1):1-8. PubMed ID: 17343766 [TBL] [Abstract][Full Text] [Related]
6. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice. Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 activity in vivo limits glucocorticoid exposure to human adipose tissue and decreases lipolysis. Tomlinson JW; Sherlock M; Hughes B; Hughes SV; Kilvington F; Bartlett W; Courtney R; Rejto P; Carley W; Stewart PM J Clin Endocrinol Metab; 2007 Mar; 92(3):857-64. PubMed ID: 17200165 [TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of 11beta-hydroxysteroid dehydrogenase activity in the rabbit eye. Anderson S; Carreiro S; Quenzer T; Gale D; Xiang C; Gukasyan H; Lafontaine J; Cheng H; Krauss A; Prasanna G J Ocul Pharmacol Ther; 2009 Jun; 25(3):215-22. PubMed ID: 19456256 [TBL] [Abstract][Full Text] [Related]
9. Tissue specific regulation of glucocorticoids in severe obesity and the response to significant weight loss following bariatric surgery (BARICORT). Woods CP; Corrigan M; Gathercole L; Taylor A; Hughes B; Gaoatswe G; Manolopoulos K; Hogan AE; O'Connell J; Stewart PM; Tomlinson JW; O'Shea D; Sherlock M J Clin Endocrinol Metab; 2015 Apr; 100(4):1434-44. PubMed ID: 25603461 [TBL] [Abstract][Full Text] [Related]
10. 11beta-hydroxysteroid dehydrogenase type 1 and obesity. Morton NM; Seckl JR Front Horm Res; 2008; 36():146-164. PubMed ID: 18230901 [TBL] [Abstract][Full Text] [Related]
11. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates. Tsilchorozidou T; Honour JW; Conway GS J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189 [TBL] [Abstract][Full Text] [Related]
12. Expression of 11β-hydroxysteroid dehydrogenase 1 and 2 in patients with chronic rhinosinusitis and their possible contribution to local glucocorticoid activation in sinus mucosa. Jun YJ; Park SJ; Kim TH; Lee SH; Lee KJ; Hwang SM; Lee SH J Allergy Clin Immunol; 2014 Oct; 134(4):926-934.e6. PubMed ID: 24810847 [TBL] [Abstract][Full Text] [Related]
13. Altered activity of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in skeletal muscle confers metabolic protection in subjects with type 2 diabetes. Jang C; Obeyesekere VR; Dilley RJ; Krozowski Z; Inder WJ; Alford FP J Clin Endocrinol Metab; 2007 Aug; 92(8):3314-20. PubMed ID: 17519316 [TBL] [Abstract][Full Text] [Related]
14. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. Ahmed A; Rabbitt E; Brady T; Brown C; Guest P; Bujalska IJ; Doig C; Newsome PN; Hubscher S; Elias E; Adams DH; Tomlinson JW; Stewart PM PLoS One; 2012; 7(2):e29531. PubMed ID: 22363403 [TBL] [Abstract][Full Text] [Related]
15. Testosterone stimulates adipose tissue 11beta-hydroxysteroid dehydrogenase type 1 expression in a depot-specific manner in children. Zhu L; Hou M; Sun B; Burén J; Zhang L; Yi J; Hernell O; Li X J Clin Endocrinol Metab; 2010 Jul; 95(7):3300-8. PubMed ID: 20410225 [TBL] [Abstract][Full Text] [Related]
16. Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men. Wake DJ; Stimson RH; Tan GD; Homer NZ; Andrew R; Karpe F; Walker BR J Clin Endocrinol Metab; 2007 May; 92(5):1848-56. PubMed ID: 17327378 [TBL] [Abstract][Full Text] [Related]
17. The expression of 11β-hydroxysteroid dehydrogenase type 1 and 2 in nasal polyp-derived epithelial cells and its possible contribution to glucocorticoid activation in nasal polyp. Kook JH; Kim HJ; Kim KW; Park SJ; Kim TH; Lim SH; Kang SH; Lee SH Am J Rhinol Allergy; 2015; 29(4):246-50. PubMed ID: 26163245 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of hepatic 5α-reductase and 11β-hydroxysteroid dehydrogenase type 1 in visceral adipose tissue is associated with hyperinsulinemia in morbidly obese patients. Baudrand R; Domínguez JM; Carvajal CA; Riquelme A; Campino C; Macchiavello S; Bozinovic M; Morales M; Pizarro M; Solis N; Escalona A; Boza C; Arrese M; Fardella CE Metabolism; 2011 Dec; 60(12):1775-80. PubMed ID: 21704348 [TBL] [Abstract][Full Text] [Related]
19. Lack of regulation of 11beta-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism. Sigurjonsdottir HA; Andrew R; Stimson RH; Johannsson G; Walker BR Eur J Endocrinol; 2009 Sep; 161(3):375-80. PubMed ID: 19549748 [TBL] [Abstract][Full Text] [Related]
20. Weight loss after gastric bypass surgery in women is followed by a metabolically favorable decrease in 11beta-hydroxysteroid dehydrogenase 1 expression in subcutaneous adipose tissue. Simonyte K; Olsson T; Näslund I; Angelhed JE; Lönn L; Mattsson C; Rask E J Clin Endocrinol Metab; 2010 Jul; 95(7):3527-31. PubMed ID: 20410231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]